Société Kancera AB (publ) Nasdaq Stockholm
Actions
SE0015658570
Recherche biotechnologique et médicale
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Peter Selin
CEO | Chief Executive Officer | - | 01/03/22 |
Director of Finance/CFO | 75 | - | |
Johan Schultz
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/13 |
Martin Norin
COO | Chief Operating Officer | 65 | 01/01/10 |
Thomas Olin
CTO | Chief Tech/Sci/R&D Officer | 66 | 05/05/10 |
Markus Jerling
CTO | Chief Tech/Sci/R&D Officer | 72 | 01/09/23 |
Niclas Brynne
PRN | Corporate Officer/Principal | 63 | 01/09/16 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Chairman | 63 | 05/05/10 | |
Director/Board Member | 66 | 01/01/16 | |
Håkan Mellstedt
FOU | Founder | 82 | 28/04/10 |
Thomas Olin
CTO | Chief Tech/Sci/R&D Officer | 66 | 05/05/10 |
Director/Board Member | 72 | 28/05/12 | |
Director/Board Member | 58 | 30/05/18 | |
Petter Brodin
BRD | Director/Board Member | - | 26/05/21 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 147 729 260 | 55 214 243 ( 37,38 %) | 0 | 37,38 % |
Coordonnées société
Kancera AB
Karolinska Institutet Science Park Nanna Svartz Väg 4
171 65, Solna
+46 8 50 12 60 80
http://www.kancera.comSecteur
Varia. 1 janv. | Capi. | |
---|---|---|
+9,99% | 115 Md | |
+12,01% | 106 Md | |
-3,07% | 24,69 Md | |
-0,99% | 21,97 Md | |
-5,01% | 19,27 Md | |
-6,90% | 17,56 Md | |
-39,36% | 17,32 Md | |
+5,82% | 14,03 Md | |
+33,05% | 12,13 Md |